We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Brown & Brown
BRO
$22.9B
| $536K | ﹤0.01% |
20,850
+434
| +2% | +$10.9K |
|
1477
CONMED
CNMD
$1.29B
| $536K | ﹤0.01% |
10,511
-228
| -2% | -$11.9K |
|
|
MDP
1478
DELISTED
Meredith Corporation
MDP
| $534K | ﹤0.01% |
8,085
-935
| -10% | -$56.4K |
|
1479
Ethan Allen Interiors
ETD
$581M
| $533K | ﹤0.01% |
18,624
+1,010
| +6% | +$29.6K |
|
1480
Monster Beverage
MNST
$91.4B
| $532K | ﹤0.01% |
16,790
+534
| +3% | +$16K |
|
1481
Nomad Foods
NOMD
$1.64B
| $532K | ﹤0.01% |
31,483
-6,442
| -17% | -$100K |
|
|
QEP
1482
DELISTED
QEP RESOURCES, INC.
QEP
| $531K | ﹤0.01% |
55,455
+3,161
| +6% | +$28.6K |
|
|
CSGS
1483
DELISTED
CSG Systems International
CSGS
| $529K | ﹤0.01% |
12,076
-2,053
| -15% | -$88.6K |
|
|
CTRA
1484
DELISTED
Coterra Energy
CTRA
| $529K | ﹤0.01% |
18,505
+1,192
| +7% | +$32.7K |
|
1485
Gentex
GNTX
$4.88B
| $529K | ﹤0.01% |
25,248
+1,095
| +5% | +$21.8K |
|
|
MDRX
1486
DELISTED
Veradigm Inc. Common Stock
MDRX
| $529K | ﹤0.01% |
36,412
+1,261
| +4% | +$17.5K |
|
|
GRA
1487
DELISTED
W.R. Grace & Co.
GRA
| $528K | ﹤0.01% |
7,523
-172
| -2% | -$12.5K |
|
1488
Sensient Technologies
SXT
$5.4B
| $526K | ﹤0.01% |
7,190
+1,286
| +22% | +$98K |
|
1489
United Therapeutics
UTHR
$26.3B
| $526K | ﹤0.01% |
3,557
+65
| +2% | +$8.26K |
|
1490
Midland States Bancorp
MSBI
$669M
| $525K | ﹤0.01% |
16,185
-1,657
| -9% | -$53.9K |
|
1491
Phibro Animal Health
PAHC
$1.38B
| $525K | ﹤0.01% |
15,681
+703
| +5% | +$25K |
|
1492
Brown-Forman Class B
BF.B
$12B
| $524K | ﹤0.01% |
11,916
-112
| -0.9% | -$4.27K |
|
1493
Cirrus Logic
CRUS
$6.74B
| $524K | ﹤0.01% |
10,110
+1,486
| +17% | +$80.3K |
|
1494
Idacorp
IDA
$8.23B
| $524K | ﹤0.01% |
5,731
+730
| +15% | +$68.2K |
|
1495
Minerals Technologies
MTX
$2.31B
| $524K | ﹤0.01% |
7,615
+288
| +4% | +$20.5K |
|
|
MSCC
1496
DELISTED
Microsemi Corp
MSCC
| $524K | ﹤0.01% |
10,149
+597
| +6% | +$31.4K |
|
1497
Universal Insurance Holdings
UVE
$1.16B
| $523K | ﹤0.01% |
19,093
-4,515
| -19% | -$113K |
|
1498
Kulicke & Soffa
KLIC
$5.3B
| $522K | ﹤0.01% |
21,453
-4,629
| -18% | -$110K |
|
1499
Varex Imaging
VREX
$460M
| $522K | ﹤0.01% |
12,992
-1,951
| -13% | -$70.1K |
|
1500
Advanced Energy
AEIS
$12.2B
| $521K | ﹤0.01% |
7,717
+1,819
| +31% | +$147K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.